Trump administration announces tariffs on $50B of Chinese goods—including medical devices

After months of statements, speculation, trade talks, tweets and threats, the U.S. government has officially put tariffs in place on $50 billion worth of products imported from China, including medical imaging equipment. X-ray, CT and MRI equipment are all on the list of products included in this announcement.

While approximately $34 billion worth of Chinese goods are covered by the initial list of items published by the Office of the United States Trade Representative (USTR), approximately $16 billion worth of items are included in a second list of items to undergo "further review in a public notice and comment process." 

 “We must take strong defensive actions to protect America’s leadership in technology and innovation against the unprecedented threat posed by China’s theft of our intellectual property, the forced transfer of American technology, and its cyber-attacks on our computer networks,” Ambassador Robert Lighthizer said in a USTR statement. “China’s government is aggressively working to undermine America’s high-tech industries and our economic leadership through unfair trade practices and industrial policies like ‘Made in China 2025.’  Technology and innovation are America’s greatest economic assets and President Trump rightfully recognizes that if we want our country to have a prosperous future, we must take a stand now to uphold fair trade and protect American competitiveness.”

China’s Commerce Ministry issued a statement in response to the news, saying the U.S. has provoked “a trade war.”

“We will immediately introduce taxation measures of the same scale and the same strength,” the statement read. "All the economic and trade achievements previously reached by the two parties will no longer be valid at the same time. In today’s era, launching a trade war is not in the global interest.”

Read more about the ongoing matter at Radiology Business here, here and here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”